Orlistat, a gastrointestinal lipase inhibitor, in therapy of obesity with concomitant hyperlipidemia.

Medicinski pregled

Volumn 52, Issue 9-10, 1999, Pages 323-333

  Micic D ^a   Ivkovic Lazar T ^a   Dragojevic R ^a   Jorga, J ^a   Stokic E ^a   Hajdukovic Z ^a  

^a UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; ENZYME INHIBITOR; LACTONE; LIPID; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL LIPASE;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; FEMALE; HUMAN; HYPERLIPIDEMIA; MALE; MIDDLE AGED; MULTICENTER STUDY; OBESITY; RANDOMIZED CONTROLLED TRIAL; WEIGHT REDUCTION;

ADULT; ANTI-OBESITY AGENTS; DOUBLE-BLIND METHOD; ENZYME INHIBITORS; FEMALE; HUMANS; HYPERLIPIDEMIAS; LACTONES; LIPASE; LIPIDS; MALE; MIDDLE AGED; OBESITY; WEIGHT LOSS;

EID: 0033183362     PISSN: 00258105     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)